Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Healthcare Financial Analytics Market

  • MAR2979342
  • 206 Pages
  • February 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Introduction

Financial analytics is expected to become the next major area of investment for healthcare providers and payers in the coming years. The financial analytics are required for claims processing; revenue cycle management (RCM); payment integrity and fraud, waste, and abuse (FWA); risk adjustment; and risk assessment. It generally works with the help of sophisticated software technology and specialized billing knowledge to keep track of the claims processed and revenue collected.

Healthcare Financial Analytics empower hospital and CFOs by providing the complete picture of profitability from various service lines - outpatient services, surgery, or labs - as well as by the doctor, or by practice. It provides the data that helps the company to make better investment decisions based on concrete costs and profits for common services. It also enables the company to better leverage their data for effective budgeting and forecasting.

Market Dynamics

Some of the major factors driving this market are the integration of big data in healthcare owing to the transition from paper charts to real-time monitoring systems, growing awareness of digital technologies, expansion of healthcare IT, technological investments, increasing investment from public and private organizations. Growing need for an effective financial management system in order to maximize claim conversion rate, reduce healthcare cost and to make the process faster will also drive the industry growth. Federal healthcare mandates, advancements in analytical technologies, digitalization of healthcare, personalized medicine will propel the growth further.

Restraints

Some of the restraining factors this market faces are data security concerns, high initial investment, lack of proper trained IT professionals, lack of coordination among different departments and also among staff of the same department, lack of patient data confidentiality and transparency, lack of interoperability, functional gap between payers and providers, increase in governmental regulation, and reimbursement issues and poor workflow.

Market Segmentation

The various market segments can be derived on the basis of type, component, deployment and end-user.

On the Basis of Type:

> Claims analytics

> Revenue cycle management

> Risk management analytics

On the Basis of Component:

> Software

> Hardware

> Services

On the Basis of Deployment:

> Cloud-based model

> Web-based model

> On-premise model

On the Basis of End-user:

> Private organization (hospitals, physicians, clinics)

> Government organization

> Insurance companies

> Others

Regional/Geographic Analysis

The market is segmented into North America, Europe, Asia Pacific and Rest of the World. U.S. market is expected to grow at the fastest rate due to presence of well-established healthcare infrastructure, increasing venture capital funding, acceptance of advanced technologies and widespread adoption of electronic health records across healthcare. The European market is expected to grow at a slightly lower rate mainly due to the economic crisis. The Asian market is fairly new to medical analytics; however, the increasing IT skills, outsourcing trend and healthcare IT adoption will force this market to emerge into fast-growing market in the future.

Key Players

IBM, Optum Health, McKesson Corporation, Allscripts Healthcare Solutions, Cerner Corporation, Athena Health, Tenet Healthcare Corporation, GE Healthcare, Evolent Health, Mede Analytics, Oracle, Vitreos Health, SCIO Health

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390